Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Interest Income Expense
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
|
Interest Income Expense
¥8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
C
|
China Hongqiao Group Ltd
HKEX:1378
|
Interest Income Expense
-¥1.1B
|
CAGR 3-Years
31%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
Shandong Nanshan Aluminium Co Ltd
SSE:600219
|
Interest Income Expense
¥173.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
A
|
Aluminum Corporation of China Ltd
SSE:601600
|
Interest Income Expense
-¥2.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Yunnan Aluminium Co Ltd
SZSE:000807
|
Interest Income Expense
-¥188.9m
|
CAGR 3-Years
33%
|
CAGR 5-Years
26%
|
CAGR 10-Years
10%
|
|
Tianshan Aluminum Group Co Ltd
SZSE:002532
|
Interest Income Expense
-¥767.2m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Interest Income Expense?
Interest Income Expense
8m
CNY
Based on the financial report for Sep 30, 2023, Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Interest Income Expense amounts to 8m CNY.
What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-3%
Over the last year, the Interest Income Expense growth was -50%. The average annual Interest Income Expense growth rates for Shanghai Haishun New Pharmaceutical Packaging Co Ltd have been -10% over the past three years , -3% over the past five years .